Showing results (41-50 of 267) with videos related to

Sort By:
Pageof 27
Archives of Gynecology and Obstetrics|November 25, 2015
Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer: first evidence for efficacyRainer Kimmig, Antonella Iannaccone, Bahriye Aktas, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Accuracy of Ultrasonography and Magnetic Resonance Imaging for Preoperative Staging of Cervical Cancer-Analysis of Patients from the Prospective Study on Total Mesometrial ResectionMaciej Stukan, Paul Buderath, Bartosz Szulczyński, et al.
Journal of Gynecologic Oncology|June 29, 2017
Early ovarian cancer surgery with indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, pelvic part)Rainer Kimmig, Paul Buderath, Peter Rusch, et al.
Archives of Gynecology and Obstetrics|August 16, 2022
Single-center study for robotic-assisted laparoscopic sacropexies: a one-fits-all strategy for pelvic organ prolapse?Pawel Mach, Cara Kaufold, Peter Rusch, et al.
O&G Open|September 26, 2025
Giant Uterine Leiomyoma Causing Severe Hemodynamic InstabilitySaed Almasarweh, Paul Buderath, Peter Rusch, et al.
International Journal of Molecular Sciences|September 25, 2019
EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer CellsNina Mallmann-Gottschalk, Yvonne Sax, Rainer Kimmig, et al.
Anticancer Research|December 26, 2012
Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancerBahriye Aktas, Sabine Kasimir-Bauer, Pauline Wimberger, et al.
Oncology Reports|April 23, 2013
Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancerBahriye Aktas, Sabine Kasimir-Bauer, Nils Lehmann, et al.
Breast Cancer Research : BCR|January 24, 2012
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsSabine Kasimir-Bauer, Oliver Hoffmann, Diethelm Wallwiener, et al.
Frontiers in Immunology|May 14, 2024
Corrigendum: Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascitesAntonio Hrvat, Sonja Benders, Rainer Kimmig, et al.
Pageof 27